Article Sidebar
Views PDF: 8
STUDY ON THE SITUATION, SOME PROGNOSTIC FACTORS AND THE TREATMENT OUTCOMES OF DEEP VEIN THROMBOSIS USING RIVAROXABAN IN CEREBRAL INFARCTION PATIENTS AT LONG AN GENERAL HOSPITAL FROM 2023 TO 2024
Main Article Content
Abstract
Background: Deep vein thrombosis (DVT) is a serious complication in patients with acute cerebral infarction, the incidence varies from 10-75%. It poses a risk of pulmonary embolism, and in severe cases, it can cause death. Objective: Survey of the rate and some factors related to deep vein thrombosis of the lower extremities in patients with cerebral infarction at Long An Provincial General Hospital. Materials and methods: A prospective study was conducted on 95 patients diagnosed with cerebral infarction admitted to Long An General Hospital with a Wells score of 2 points or more from April 2023 to April 2024. Results: Regarding the general characteristic: the average age was 70.1 ±10.7, most cases was ≥60 years old, male accounted 52.7%, female accounted 47.3%. The obesity rate among patients was 24.2%, history of hypertension was 81.1%, type 2 diabetes was 46.9% and smoking was 35.8%. the rate of lower limb deep vein thrombosis in patients with cerebral infarction was 24.2%, There was a correlation between vein thrombosis in the lower limbs and factors such as: age (p=0.014) and obesity increases the risk of deep vein thrombosis in the lower limbs by 5 times with p=0.016. Conclusion: Deep vein thrombosis in the lower limbs in patients cerebral infarction had a high rate (24.2%), the occurrence of deep vein thrombosis was associated with age and obesity.
Article Details
Keywords
Deep vein thrombosis, associated factors, cerebral infarction
References
2020. 15(9), 1770-1781. doi: 10.1111/jth.13769.
2. Liu Z., Liu D., Guo Z.N., Hang Jin, Tong Sun, et al. Incidence and risk factors of lowerextremity deep vein thrombosis after thrombolysis among patients with acute ischemic stroke. Pharmacogenomics and Personalized Medicine. 2021. 8, 1107- 1114. doi: 10.2147/PGPM.S321084.
3. Tøndel B. G., Morelli V. M., Hansen J. B. Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systemati review. Journal of Thrombosis and Haemostasis. 2022. 20(10), 2173-2186. doi: 10.1111/jth.15489.
4. D Gatot, A I Mardia. Differences of wells scores accuracy, caprini scores and padua scores in deep vein thrombosis diagnosis. United Through Science & Technology. 2018. 012131, doi:10.1088/1755-1315/125/1/012131.
5. Nguyễn Văn Diệu. Khảo sát huyết khối tĩnh mạch sâu chi dưới không triệu chứng trên bệnh nhân nhồi máu não nằm viện. Tạp chí Y Dược Huế. 2017. Tập 7, số 2 - tháng 4/2017, 74-78. doi: 10.34071/jmp.2017.2.13.
6. Duy K. N., Nguyen, D. T., Van Le, M., Le, L. D., Tran, H. C. et al. Enoxaparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. Trends in Medical Sciences. 2022. volume 2, issue 1, 1-8. doi: https://doi.org/10.5812/tms-122415.
7. Li Fang., Wei C, Su Huo, Xiuzhen Liu, Jubao Du. Predictors of deep-vein thrombosis for acute stroke at admission to a rehabilitation unit: A retrospective study. Frontiers in Neurology. 2023. 14, 1137485, doi: 10.3389/fneur.2023.1137485.
8. Han L., Yang J.M., Qian W.Y., Xu X.P., Tung T.H., et al. Risk factors for lower extremity deep vein thrombosis in acute stroke patients following endovascular thrombectomy: a retrospective cohort study. Frontiers in Neurology. 2023. volume 14, 1249365. doi:
10.3389/fneur.2023.1249365.
9. Chopard R., Albertsen I.E., Piazza G. Diagnosis and Treatment of Lower Extremity Venous
Thromboembolism: A Review. JAMA. 2020. 324(17), 1765-1776. doi:
10.1001/jama.2020.17272.
10. Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep. 2020. 93(2), 162-168. doi: 10.15386/mpr-1372.